Infection severity across scales in multi-strain immuno-epidemiological Dengue model structured by host antibody level

Infection by distinct Dengue virus serotypes and host immunity are intricately linked. In particular, certain levels of cross-reactive antibodies in the host may actually enhance infection severity leading to Dengue hemorrhagic fever (DHF). The coupled immunological and epidemiological dynamics of Dengue calls for a multi-scale modeling approach. In this work, we formulate a within-host model which mechanistically recapitulates characteristics of antibody dependent enhancement in Dengue infection. The within-host scale is then linked to epidemiological spread by a vector–host partial differential equation model structured by host antibody level. The coupling allows for dynamic population-wide antibody levels to be tracked through primary and secondary infections by distinct Dengue strains, along with waning of cross-protective immunity after primary infection. Analysis of both the within-host and between-host systems are conducted. Stability results in the epidemic model are formulated via basic and invasion reproduction numbers as a function of immunological variables. Additionally, we develop numerical methods in order to simulate the multi-scale model and assess the influence of parameters on disease spread and DHF prevalence in the population.

[1]  Stanca M. Ciupe,et al.  Unraveling within-host signatures of dengue infection at the population level. , 2018, Journal of theoretical biology.

[2]  Edward C. Holmes,et al.  Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes , 2013, Proceedings of the National Academy of Sciences.

[3]  Stanca M. Ciupe,et al.  The role of antibody in enhancing dengue virus infection. , 2015, Mathematical biosciences.

[4]  Nico Stollenwerk,et al.  The risks behind Dengvaxia recommendation. , 2016, The Lancet. Infectious diseases.

[5]  Simon Cauchemez,et al.  Reconstruction of antibody dynamics and infection histories to evaluate dengue risk , 2018, Nature.

[6]  Rinaldo M. Colombo,et al.  Structured Populations, Cell Growth and Measure Valued Balance Laws , 2012 .

[7]  E. Harris,et al.  Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort , 2016, Proceedings of the National Academy of Sciences.

[8]  Azmy S. Ackleh,et al.  A STRUCTURED MODEL FOR THE SPREAD OF MYCOBACTERIUM MARINUM : FOUNDATIONS FOR A NUMERICAL APPROXIMATION SCHEME , 2014 .

[9]  A. Pugliese The role of host population heterogeneity in the evolution of virulence , 2011, Journal of biological dynamics.

[10]  Prida Malasit,et al.  Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans , 2010, Science.

[11]  Akira Sasaki,et al.  Modeling host-parasite coevolution: a nested approach based on mechanistic models. , 2002, Journal of theoretical biology.

[12]  H. Gulbudak AN IMMUNO-EPIDEMIOLOGICAL VECTOR–HOST MODEL WITH WITHIN-VECTOR VIRAL KINETICS , 2019, Journal of Biological Systems.

[13]  Carmela Sinisgalli,et al.  Epidemic dynamics and host immune response: a nested approach , 2014, Journal of Mathematical Biology.

[14]  Maia Martcheva,et al.  Structural and Practical Identifiability Issues of Immuno-Epidemiological Vector–Host Models with Application to Rift Valley Fever , 2016, Bulletin of Mathematical Biology.

[15]  Andreas Handel,et al.  Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[16]  T. Pierson,et al.  Antibody-mediated neutralization of flaviviruses: a reductionist view. , 2011, Virology.

[17]  M. Halloran,et al.  Reply to Aguiar and Stollenwerk. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  V. Veliov,et al.  Modelling and estimation of infectious diseases in a population with heterogeneous dynamic immunity , 2016, Journal of biological dynamics.

[19]  Pejman Rohani,et al.  Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity , 2013, Journal of The Royal Society Interface.

[20]  Sergei S. Pilyugin,et al.  AN EPIDEMIC MODEL STRUCTURED BY HOST IMMUNITY , 2006 .

[21]  S. Pilyugin,et al.  GLOBAL ANALYSIS OF AGE-STRUCTURED WITHIN-HOST VIRUS MODEL , 2013 .

[22]  Bob W. Kooi,et al.  Epidemiology of Dengue Fever: A Model with Temporary Cross-Immunity and Possible Secondary Infection Shows Bifurcations and Chaotic Behaviour in Wide Parameter Regions , 2008 .

[23]  Ira B Schwartz,et al.  Dynamic effects of antibody-dependent enhancement on the fitness of viruses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Stollenwerk,et al.  Mathematical models of dengue fever epidemiology: multi-strain dynamics, immunological aspects associated to disease severity and vaccines , 2017 .

[25]  Katia Koelle,et al.  Minimal within-host dengue models highlight the specific roles of the immune response in primary and secondary dengue infections , 2015, Journal of The Royal Society Interface.

[26]  Melanie I. Stefan,et al.  Cooperative Binding , 2013, PLoS Comput. Biol..

[27]  Cameron P. Simmons,et al.  Modelling Virus and Antibody Dynamics during Dengue Virus Infection Suggests a Role for Antibody in Virus Clearance , 2016, PLoS Comput. Biol..

[28]  M. V. Barbarossa,et al.  Immuno-epidemiology of a population structured by immune status: a mathematical study of waning immunity and immune system boosting , 2014, Journal of Mathematical Biology.

[29]  Horst R Thiemea “Integrated semigroups” and integrated solutions to abstract Cauchy problems , 1990 .

[30]  Daniel J. Laydon,et al.  Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment , 2016, Science.

[31]  Maia Martcheva,et al.  Forward hysteresis and backward bifurcation caused by culling in an avian influenza model. , 2013, Mathematical biosciences.

[32]  A. Wallqvist,et al.  Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus , 2019, Front. Cell. Infect. Microbiol..

[33]  N. Ferguson,et al.  The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Halloran,et al.  Antibody-dependent enhancement of severe dengue disease in humans , 2017, Science.

[35]  Tanvi P. Gujarati,et al.  Virus antibody dynamics in primary and secondary dengue infections , 2012, Journal of Mathematical Biology.

[36]  O. Diekmann,et al.  Waning and boosting: on the dynamics of immune status , 2018, Journal of mathematical biology.

[37]  A. Handel,et al.  Heterogeneity and longevity of antibody memory to viruses and vaccines , 2018, PLoS biology.

[38]  Pejman Rohani,et al.  Ecological and immunological determinants of dengue epidemics. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. D. de Silva,et al.  The Human Antibody Response to Dengue Virus Infection , 2011, Viruses.

[40]  Stanca M. Ciupe,et al.  Modelling original antigenic sin in dengue viral infection. , 2018, Mathematical medicine and biology : a journal of the IMA.

[41]  M. Martcheva,et al.  Vector-Borne Pathogen and Host Evolution in a Structured Immuno-Epidemiological System , 2017, Bulletin of Mathematical Biology.